Open AccessS0881 Therapeutic Drug Monitoring Dosing Regimen With Adalimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the SERENE-UC Maintenance Study
Author(s) -
Jean–Frédéric Colombel,
Julián Panés,
Geert R. D’Haens,
Stefan Schreiber,
Remo Panaccione,
Laurent PeyrinBiroulet,
Edward V. Loftus,
Silvio Danese,
Édouard Louis,
Alessandro Armuzzi,
Marc Ferrante,
Harald Vogelsang,
Nael M. Mostafa,
Thao Doan,
Wenhui Xie,
Joel Petersson,
Jasmina Kalabic,
Anne Robinson,
William J. Sandborn
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705572.04908.5f
Subject(s) - medicine , ulcerative colitis , dosing , regimen , therapeutic drug monitoring , maintenance therapy , adalimumab , randomized controlled trial , maintenance dose , pharmacokinetics , surgery , chemotherapy , disease